nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Bicalutamide—prostate cancer	0.123	0.294	CbGbCtD
Glimepiride—CYP2C9—Nilutamide—prostate cancer	0.123	0.294	CbGbCtD
Glimepiride—CYP2C9—Estrone—prostate cancer	0.0737	0.176	CbGbCtD
Glimepiride—CYP2C9—Capecitabine—prostate cancer	0.0559	0.134	CbGbCtD
Glimepiride—CYP2C9—Estradiol—prostate cancer	0.0423	0.101	CbGbCtD
Glimepiride—ABCC8—penis—prostate cancer	0.0234	0.42	CbGeAlD
Glimepiride—CYP2C9—urine—prostate cancer	0.00697	0.125	CbGeAlD
Glimepiride—KCNJ1—renal system—prostate cancer	0.00683	0.122	CbGeAlD
Glimepiride—ABCC8—prostate gland—prostate cancer	0.0056	0.1	CbGeAlD
Glimepiride—ABCC8—seminal vesicle—prostate cancer	0.00474	0.0849	CbGeAlD
Glimepiride—ABCC8—renal system—prostate cancer	0.00382	0.0684	CbGeAlD
Glimepiride—ABCC8—testis—prostate cancer	0.00247	0.0442	CbGeAlD
Glimepiride—KCNJ11—lymph node—prostate cancer	0.00194	0.0348	CbGeAlD
Glimepiride—Gliclazide—VEGFA—prostate cancer	0.0017	0.263	CrCbGaD
Glimepiride—Tolbutamide—CYP2C18—prostate cancer	0.00139	0.216	CrCbGaD
Glimepiride—Gliclazide—CYP2C19—prostate cancer	0.000825	0.128	CrCbGaD
Glimepiride—Chlorpropamide—CYP2C19—prostate cancer	0.000641	0.0993	CrCbGaD
Glimepiride—Tolbutamide—CYP2C19—prostate cancer	0.000625	0.0968	CrCbGaD
Glimepiride—Glipizide—CYP3A4—prostate cancer	0.000564	0.0873	CrCbGaD
Glimepiride—Glyburide—CYP2C19—prostate cancer	0.000433	0.0671	CrCbGaD
Glimepiride—Glyburide—CYP3A4—prostate cancer	0.000275	0.0426	CrCbGaD
Glimepiride—Photosensitivity reaction—Epirubicin—prostate cancer	0.000185	0.000479	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—prostate cancer	0.000185	0.000478	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—prostate cancer	0.000185	0.000478	CcSEcCtD
Glimepiride—Loss of consciousness—Docetaxel—prostate cancer	0.000184	0.000477	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—prostate cancer	0.000184	0.000475	CcSEcCtD
Glimepiride—Somnolence—Etoposide—prostate cancer	0.000183	0.000473	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—prostate cancer	0.000183	0.000473	CcSEcCtD
Glimepiride—Hypersensitivity—Mitoxantrone—prostate cancer	0.000182	0.000472	CcSEcCtD
Glimepiride—Diarrhoea—Estradiol—prostate cancer	0.000182	0.00047	CcSEcCtD
Glimepiride—Leukopenia—Capecitabine—prostate cancer	0.000182	0.00047	CcSEcCtD
Glimepiride—Convulsion—Docetaxel—prostate cancer	0.000182	0.00047	CcSEcCtD
Glimepiride—Hypertension—Docetaxel—prostate cancer	0.000181	0.000468	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—prostate cancer	0.000181	0.000468	CcSEcCtD
Glimepiride—Malnutrition—Prednisone—prostate cancer	0.000181	0.000468	CcSEcCtD
Glimepiride—Erythema—Prednisone—prostate cancer	0.000181	0.000468	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000179	0.000464	CcSEcCtD
Glimepiride—Palpitations—Capecitabine—prostate cancer	0.000179	0.000464	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—prostate cancer	0.000179	0.000463	CcSEcCtD
Glimepiride—Loss of consciousness—Capecitabine—prostate cancer	0.000178	0.000461	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—prostate cancer	0.000178	0.000461	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—prostate cancer	0.000178	0.00046	CcSEcCtD
Glimepiride—Asthenia—Mitoxantrone—prostate cancer	0.000178	0.000459	CcSEcCtD
Glimepiride—Fatigue—Etoposide—prostate cancer	0.000178	0.000459	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—prostate cancer	0.000176	0.000456	CcSEcCtD
Glimepiride—Dizziness—Estradiol—prostate cancer	0.000176	0.000454	CcSEcCtD
Glimepiride—Hypertension—Capecitabine—prostate cancer	0.000175	0.000453	CcSEcCtD
Glimepiride—Dry mouth—Docetaxel—prostate cancer	0.000175	0.000451	CcSEcCtD
Glimepiride—Sweating—Epirubicin—prostate cancer	0.000174	0.000449	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—prostate cancer	0.000174	0.000449	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—prostate cancer	0.000173	0.000446	CcSEcCtD
Glimepiride—Anxiety—Capecitabine—prostate cancer	0.000172	0.000445	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000171	0.000443	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—prostate cancer	0.000171	0.000443	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—prostate cancer	0.000171	0.000442	CcSEcCtD
Glimepiride—Vision blurred—Prednisone—prostate cancer	0.00017	0.000441	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—prostate cancer	0.00017	0.000439	CcSEcCtD
Glimepiride—Diarrhoea—Mitoxantrone—prostate cancer	0.000169	0.000438	CcSEcCtD
Glimepiride—Dry mouth—Capecitabine—prostate cancer	0.000169	0.000437	CcSEcCtD
Glimepiride—Vomiting—Estradiol—prostate cancer	0.000169	0.000437	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—prostate cancer	0.000169	0.000437	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—prostate cancer	0.000168	0.000435	CcSEcCtD
Glimepiride—Shock—Docetaxel—prostate cancer	0.000168	0.000435	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—prostate cancer	0.000168	0.000433	CcSEcCtD
Glimepiride—Rash—Estradiol—prostate cancer	0.000168	0.000433	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—prostate cancer	0.000168	0.000433	CcSEcCtD
Glimepiride—Dermatitis—Estradiol—prostate cancer	0.000167	0.000433	CcSEcCtD
Glimepiride—Anaemia—Prednisone—prostate cancer	0.000167	0.000432	CcSEcCtD
Glimepiride—Confusional state—Capecitabine—prostate cancer	0.000167	0.000432	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—prostate cancer	0.000167	0.000432	CcSEcCtD
Glimepiride—Headache—Estradiol—prostate cancer	0.000166	0.00043	CcSEcCtD
Glimepiride—Agitation—Prednisone—prostate cancer	0.000166	0.00043	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000166	0.000429	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—prostate cancer	0.000165	0.000428	CcSEcCtD
Glimepiride—Angioedema—Prednisone—prostate cancer	0.000165	0.000427	CcSEcCtD
Glimepiride—Urticaria—Etoposide—prostate cancer	0.000164	0.000423	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—prostate cancer	0.000163	0.000422	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—prostate cancer	0.000163	0.000422	CcSEcCtD
Glimepiride—Shock—Capecitabine—prostate cancer	0.000163	0.000422	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—prostate cancer	0.000163	0.000421	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—prostate cancer	0.000163	0.00042	CcSEcCtD
Glimepiride—Thrombocytopenia—Capecitabine—prostate cancer	0.000162	0.000419	CcSEcCtD
Glimepiride—Tachycardia—Capecitabine—prostate cancer	0.000162	0.000418	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—prostate cancer	0.000161	0.000415	CcSEcCtD
Glimepiride—Hyperhidrosis—Capecitabine—prostate cancer	0.00016	0.000414	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—prostate cancer	0.00016	0.000413	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisone—prostate cancer	0.000159	0.000411	CcSEcCtD
Glimepiride—Anorexia—Capecitabine—prostate cancer	0.000158	0.000408	CcSEcCtD
Glimepiride—Nausea—Estradiol—prostate cancer	0.000158	0.000408	CcSEcCtD
Glimepiride—Vomiting—Mitoxantrone—prostate cancer	0.000157	0.000407	CcSEcCtD
Glimepiride—Convulsion—Prednisone—prostate cancer	0.000157	0.000405	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—prostate cancer	0.000157	0.000405	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—prostate cancer	0.000156	0.000404	CcSEcCtD
Glimepiride—Hypertension—Prednisone—prostate cancer	0.000156	0.000404	CcSEcCtD
Glimepiride—Rash—Mitoxantrone—prostate cancer	0.000156	0.000404	CcSEcCtD
Glimepiride—Dermatitis—Mitoxantrone—prostate cancer	0.000156	0.000403	CcSEcCtD
Glimepiride—Headache—Mitoxantrone—prostate cancer	0.000155	0.000401	CcSEcCtD
Glimepiride—Hypotension—Capecitabine—prostate cancer	0.000155	0.0004	CcSEcCtD
Glimepiride—Insomnia—Docetaxel—prostate cancer	0.000155	0.0004	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—prostate cancer	0.000154	0.000397	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—prostate cancer	0.000154	0.000397	CcSEcCtD
Glimepiride—Anxiety—Prednisone—prostate cancer	0.000153	0.000397	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—prostate cancer	0.000153	0.000396	CcSEcCtD
Glimepiride—Dyspnoea—Docetaxel—prostate cancer	0.000153	0.000395	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—prostate cancer	0.000152	0.000393	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—prostate cancer	0.000152	0.000392	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—prostate cancer	0.000151	0.00039	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—prostate cancer	0.00015	0.000389	CcSEcCtD
Glimepiride—Insomnia—Capecitabine—prostate cancer	0.00015	0.000387	CcSEcCtD
Glimepiride—Paraesthesia—Capecitabine—prostate cancer	0.000149	0.000385	CcSEcCtD
Glimepiride—Decreased appetite—Docetaxel—prostate cancer	0.000149	0.000385	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000148	0.000382	CcSEcCtD
Glimepiride—Asthenia—Etoposide—prostate cancer	0.000148	0.000382	CcSEcCtD
Glimepiride—Dyspnoea—Capecitabine—prostate cancer	0.000148	0.000382	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—prostate cancer	0.000148	0.000382	CcSEcCtD
Glimepiride—Fatigue—Docetaxel—prostate cancer	0.000148	0.000382	CcSEcCtD
Glimepiride—Nausea—Mitoxantrone—prostate cancer	0.000147	0.00038	CcSEcCtD
Glimepiride—Dyspepsia—Capecitabine—prostate cancer	0.000146	0.000377	CcSEcCtD
Glimepiride—Pruritus—Etoposide—prostate cancer	0.000146	0.000377	CcSEcCtD
Glimepiride—Shock—Prednisone—prostate cancer	0.000145	0.000375	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—prostate cancer	0.000145	0.000375	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—prostate cancer	0.000145	0.000375	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—prostate cancer	0.000144	0.000372	CcSEcCtD
Glimepiride—Decreased appetite—Capecitabine—prostate cancer	0.000144	0.000372	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000143	0.00037	CcSEcCtD
Glimepiride—Fatigue—Capecitabine—prostate cancer	0.000143	0.000369	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—prostate cancer	0.000143	0.000369	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—prostate cancer	0.000142	0.000368	CcSEcCtD
Glimepiride—Erythema—Epirubicin—prostate cancer	0.000141	0.000366	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—prostate cancer	0.000141	0.000366	CcSEcCtD
Glimepiride—Feeling abnormal—Docetaxel—prostate cancer	0.000141	0.000365	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—prostate cancer	0.000141	0.000364	CcSEcCtD
Glimepiride—Anorexia—Prednisone—prostate cancer	0.000141	0.000364	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—prostate cancer	0.00014	0.000362	CcSEcCtD
Glimepiride—Tension—Epirubicin—prostate cancer	0.000139	0.000359	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—prostate cancer	0.000137	0.000355	CcSEcCtD
Glimepiride—Feeling abnormal—Capecitabine—prostate cancer	0.000137	0.000353	CcSEcCtD
Glimepiride—Dizziness—Etoposide—prostate cancer	0.000136	0.000352	CcSEcCtD
Glimepiride—Gastrointestinal pain—Capecitabine—prostate cancer	0.000136	0.00035	CcSEcCtD
Glimepiride—Abdominal pain—Docetaxel—prostate cancer	0.000135	0.00035	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—prostate cancer	0.000134	0.000347	CcSEcCtD
Glimepiride—Insomnia—Prednisone—prostate cancer	0.000134	0.000345	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—prostate cancer	0.000133	0.000345	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—prostate cancer	0.000133	0.000343	CcSEcCtD
Glimepiride—Urticaria—Capecitabine—prostate cancer	0.000132	0.00034	CcSEcCtD
Glimepiride—Abdominal pain—Capecitabine—prostate cancer	0.000131	0.000339	CcSEcCtD
Glimepiride—Vomiting—Etoposide—prostate cancer	0.000131	0.000339	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—prostate cancer	0.000131	0.000338	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—prostate cancer	0.000131	0.000338	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—prostate cancer	0.000131	0.000338	CcSEcCtD
Glimepiride—Agitation—Epirubicin—prostate cancer	0.00013	0.000336	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—prostate cancer	0.00013	0.000336	CcSEcCtD
Glimepiride—Rash—Etoposide—prostate cancer	0.00013	0.000336	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—prostate cancer	0.00013	0.000335	CcSEcCtD
Glimepiride—Headache—Etoposide—prostate cancer	0.000129	0.000334	CcSEcCtD
Glimepiride—Tension—Doxorubicin—prostate cancer	0.000128	0.000332	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—prostate cancer	0.000128	0.000332	CcSEcCtD
Glimepiride—Fatigue—Prednisone—prostate cancer	0.000127	0.000329	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—prostate cancer	0.000127	0.000329	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—prostate cancer	0.000127	0.000327	CcSEcCtD
Glimepiride—Hypersensitivity—Docetaxel—prostate cancer	0.000126	0.000326	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—prostate cancer	0.000125	0.000323	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—prostate cancer	0.000124	0.000321	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—prostate cancer	0.000123	0.000319	CcSEcCtD
Glimepiride—Asthenia—Docetaxel—prostate cancer	0.000123	0.000317	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—prostate cancer	0.000123	0.000317	CcSEcCtD
Glimepiride—Nausea—Etoposide—prostate cancer	0.000122	0.000316	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—prostate cancer	0.000122	0.000316	CcSEcCtD
Glimepiride—Hypersensitivity—Capecitabine—prostate cancer	0.000122	0.000316	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisone—prostate cancer	0.000122	0.000314	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—prostate cancer	0.000121	0.000313	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—prostate cancer	0.000121	0.000313	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—prostate cancer	0.000121	0.000312	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—prostate cancer	0.00012	0.000311	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—prostate cancer	0.00012	0.00031	CcSEcCtD
Glimepiride—Asthenia—Capecitabine—prostate cancer	0.000119	0.000307	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—prostate cancer	0.000118	0.000304	CcSEcCtD
Glimepiride—Urticaria—Prednisone—prostate cancer	0.000117	0.000303	CcSEcCtD
Glimepiride—Pruritus—Capecitabine—prostate cancer	0.000117	0.000303	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—prostate cancer	0.000117	0.000303	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—prostate cancer	0.000117	0.000303	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—prostate cancer	0.000117	0.000302	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—prostate cancer	0.000116	0.000301	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—prostate cancer	0.000116	0.000299	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—prostate cancer	0.000115	0.000298	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—prostate cancer	0.000115	0.000297	CcSEcCtD
Glimepiride—Shock—Epirubicin—prostate cancer	0.000114	0.000294	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—prostate cancer	0.000113	0.000293	CcSEcCtD
Glimepiride—Diarrhoea—Capecitabine—prostate cancer	0.000113	0.000293	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—prostate cancer	0.000113	0.000293	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—prostate cancer	0.000113	0.000292	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—prostate cancer	0.000113	0.000292	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—prostate cancer	0.000113	0.000291	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—prostate cancer	0.000112	0.000289	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—prostate cancer	0.000111	0.000287	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—prostate cancer	0.00011	0.000285	CcSEcCtD
Glimepiride—Dizziness—Capecitabine—prostate cancer	0.00011	0.000283	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—prostate cancer	0.000109	0.000282	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—prostate cancer	0.000109	0.000281	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisone—prostate cancer	0.000109	0.000281	CcSEcCtD
Glimepiride—Rash—Docetaxel—prostate cancer	0.000108	0.000279	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—prostate cancer	0.000108	0.000279	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—prostate cancer	0.000108	0.000279	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—prostate cancer	0.000108	0.000278	CcSEcCtD
Glimepiride—Headache—Docetaxel—prostate cancer	0.000107	0.000277	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—prostate cancer	0.000107	0.000276	CcSEcCtD
Glimepiride—Asthenia—Prednisone—prostate cancer	0.000106	0.000274	CcSEcCtD
Glimepiride—Vomiting—Capecitabine—prostate cancer	0.000105	0.000272	CcSEcCtD
Glimepiride—Shock—Doxorubicin—prostate cancer	0.000105	0.000272	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—prostate cancer	0.000105	0.00027	CcSEcCtD
Glimepiride—Rash—Capecitabine—prostate cancer	0.000104	0.00027	CcSEcCtD
Glimepiride—Pruritus—Prednisone—prostate cancer	0.000104	0.00027	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—prostate cancer	0.000104	0.00027	CcSEcCtD
Glimepiride—Dermatitis—Capecitabine—prostate cancer	0.000104	0.00027	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—prostate cancer	0.000104	0.00027	CcSEcCtD
Glimepiride—Headache—Capecitabine—prostate cancer	0.000104	0.000268	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—prostate cancer	0.000104	0.000268	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—prostate cancer	0.000103	0.000267	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—prostate cancer	0.000103	0.000266	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—prostate cancer	0.000103	0.000265	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—prostate cancer	0.000102	0.000263	CcSEcCtD
Glimepiride—Nausea—Docetaxel—prostate cancer	0.000102	0.000263	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—prostate cancer	0.000102	0.000263	CcSEcCtD
Glimepiride—Diarrhoea—Prednisone—prostate cancer	0.000101	0.000261	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—prostate cancer	0.0001	0.000259	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—prostate cancer	9.98e-05	0.000258	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—prostate cancer	9.97e-05	0.000258	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—prostate cancer	9.95e-05	0.000257	CcSEcCtD
Glimepiride—Nausea—Capecitabine—prostate cancer	9.84e-05	0.000254	CcSEcCtD
Glimepiride—Dizziness—Prednisone—prostate cancer	9.76e-05	0.000252	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—prostate cancer	9.66e-05	0.00025	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—prostate cancer	9.59e-05	0.000248	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—prostate cancer	9.52e-05	0.000246	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—prostate cancer	9.51e-05	0.000246	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—prostate cancer	9.5e-05	0.000246	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—prostate cancer	9.44e-05	0.000244	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—prostate cancer	9.4e-05	0.000243	CcSEcCtD
Glimepiride—Vomiting—Prednisone—prostate cancer	9.39e-05	0.000243	CcSEcCtD
Glimepiride—Rash—Prednisone—prostate cancer	9.31e-05	0.000241	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—prostate cancer	9.3e-05	0.00024	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—prostate cancer	9.29e-05	0.00024	CcSEcCtD
Glimepiride—Headache—Prednisone—prostate cancer	9.25e-05	0.000239	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.22e-05	0.000238	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—prostate cancer	9.21e-05	0.000238	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—prostate cancer	9.17e-05	0.000237	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—prostate cancer	9.13e-05	0.000236	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—prostate cancer	8.8e-05	0.000228	CcSEcCtD
Glimepiride—Nausea—Prednisone—prostate cancer	8.77e-05	0.000227	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—prostate cancer	8.74e-05	0.000226	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—prostate cancer	8.51e-05	0.00022	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—prostate cancer	8.49e-05	0.000219	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—prostate cancer	8.45e-05	0.000218	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—prostate cancer	8.28e-05	0.000214	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—prostate cancer	8.17e-05	0.000211	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—prostate cancer	7.9e-05	0.000204	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—prostate cancer	7.87e-05	0.000203	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GGT1—prostate cancer	7.8e-05	0.000587	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	7.76e-05	0.000585	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC22A1—prostate cancer	7.72e-05	0.000581	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PPARA—prostate cancer	7.72e-05	0.000581	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—P4HB—prostate cancer	7.7e-05	0.00058	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—NCOA1—prostate cancer	7.68e-05	0.000578	CbGpPWpGaD
Glimepiride—Asthenia—Doxorubicin—prostate cancer	7.66e-05	0.000198	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—prostate cancer	7.64e-05	0.000197	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP19A1—prostate cancer	7.57e-05	0.00057	CbGpPWpGaD
Glimepiride—Pruritus—Doxorubicin—prostate cancer	7.56e-05	0.000195	CcSEcCtD
Glimepiride—ABCC8—Metabolism—SULT2A1—prostate cancer	7.52e-05	0.000567	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC22A1—prostate cancer	7.49e-05	0.000564	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP19A1—prostate cancer	7.46e-05	0.000562	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MED12—prostate cancer	7.4e-05	0.000557	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNG5—prostate cancer	7.34e-05	0.000553	CbGpPWpGaD
Glimepiride—Vomiting—Epirubicin—prostate cancer	7.34e-05	0.00019	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—prostate cancer	7.31e-05	0.000189	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—RXRA—prostate cancer	7.3e-05	0.00055	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	7.3e-05	0.00055	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SULT2A1—prostate cancer	7.3e-05	0.000549	CbGpPWpGaD
Glimepiride—Rash—Epirubicin—prostate cancer	7.28e-05	0.000188	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—prostate cancer	7.27e-05	0.000188	CcSEcCtD
Glimepiride—Headache—Epirubicin—prostate cancer	7.23e-05	0.000187	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—MED12—prostate cancer	7.18e-05	0.000541	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNG5—prostate cancer	7.12e-05	0.000536	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	7.1e-05	0.000535	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA3—prostate cancer	7.07e-05	0.000533	CbGpPWpGaD
Glimepiride—Dizziness—Doxorubicin—prostate cancer	7.06e-05	0.000183	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—COMT—prostate cancer	7.04e-05	0.00053	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—prostate cancer	7e-05	0.000527	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—COMT—prostate cancer	6.94e-05	0.000522	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	6.92e-05	0.000521	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—prostate cancer	6.91e-05	0.00052	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA3—prostate cancer	6.86e-05	0.000517	CbGpPWpGaD
Glimepiride—Nausea—Epirubicin—prostate cancer	6.86e-05	0.000177	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—prostate cancer	6.79e-05	0.000176	CcSEcCtD
Glimepiride—ABCC8—Metabolism—HPGDS—prostate cancer	6.75e-05	0.000508	CbGpPWpGaD
Glimepiride—Rash—Doxorubicin—prostate cancer	6.74e-05	0.000174	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—prostate cancer	6.73e-05	0.000174	CcSEcCtD
Glimepiride—ABCC8—Metabolism—CYP2C19—prostate cancer	6.71e-05	0.000505	CbGpPWpGaD
Glimepiride—Headache—Doxorubicin—prostate cancer	6.69e-05	0.000173	CcSEcCtD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	6.6e-05	0.000497	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	6.6e-05	0.000497	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACHE—prostate cancer	6.55e-05	0.000493	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—prostate cancer	6.55e-05	0.000493	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HPGDS—prostate cancer	6.54e-05	0.000493	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2C19—prostate cancer	6.5e-05	0.00049	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2A6—prostate cancer	6.47e-05	0.000487	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—prostate cancer	6.43e-05	0.000485	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACHE—prostate cancer	6.35e-05	0.000478	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—prostate cancer	6.35e-05	0.000478	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—prostate cancer	6.35e-05	0.000478	CbGpPWpGaD
Glimepiride—Nausea—Doxorubicin—prostate cancer	6.35e-05	0.000164	CcSEcCtD
Glimepiride—ABCC8—Metabolism—AKR1C3—prostate cancer	6.29e-05	0.000474	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2A6—prostate cancer	6.27e-05	0.000472	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PRKACB—prostate cancer	6.26e-05	0.000471	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP17A1—prostate cancer	6.2e-05	0.000467	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.13e-05	0.000461	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKR1C3—prostate cancer	6.1e-05	0.00046	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—prostate cancer	6.1e-05	0.000459	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PRKACB—prostate cancer	6.07e-05	0.000457	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HAO1—prostate cancer	6.02e-05	0.000453	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—prostate cancer	6.02e-05	0.000453	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP17A1—prostate cancer	6.01e-05	0.000452	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA2—prostate cancer	5.9e-05	0.000445	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA2—prostate cancer	5.73e-05	0.000431	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC5A5—prostate cancer	5.63e-05	0.000424	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	5.61e-05	0.000423	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2E1—prostate cancer	5.5e-05	0.000414	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A5—prostate cancer	5.46e-05	0.000411	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NQO1—prostate cancer	5.44e-05	0.00041	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	5.38e-05	0.000405	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TH—prostate cancer	5.36e-05	0.000404	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2E1—prostate cancer	5.33e-05	0.000402	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP3A4—prostate cancer	5.31e-05	0.000399	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NQO1—prostate cancer	5.28e-05	0.000397	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1B1—prostate cancer	5.22e-05	0.000393	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TH—prostate cancer	5.2e-05	0.000391	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	5.18e-05	0.00039	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP3A4—prostate cancer	5.14e-05	0.000387	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1B1—prostate cancer	5.06e-05	0.000381	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GGT1—prostate cancer	5.05e-05	0.00038	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	5e-05	0.000377	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA1—prostate cancer	4.98e-05	0.000375	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CSAD—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TST—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CBR1—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GRHL1—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PSAT1—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADI1—prostate cancer	4.91e-05	0.00037	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP19A1—prostate cancer	4.9e-05	0.000369	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GGT1—prostate cancer	4.9e-05	0.000369	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA1—prostate cancer	4.82e-05	0.000363	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.8e-05	0.000361	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP19A1—prostate cancer	4.75e-05	0.000358	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—RXRA—prostate cancer	4.73e-05	0.000356	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.7e-05	0.000354	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—RXRA—prostate cancer	4.59e-05	0.000346	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UGT2B15—prostate cancer	4.56e-05	0.000344	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UGT2B17—prostate cancer	4.56e-05	0.000344	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GRHPR—prostate cancer	4.56e-05	0.000344	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CKMT2—prostate cancer	4.56e-05	0.000344	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—COMT—prostate cancer	4.56e-05	0.000343	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—prostate cancer	4.54e-05	0.000342	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ITPR1—prostate cancer	4.46e-05	0.000336	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.46e-05	0.000336	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—COMT—prostate cancer	4.42e-05	0.000333	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—prostate cancer	4.4e-05	0.000331	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.39e-05	0.00033	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ITPR1—prostate cancer	4.33e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AOX1—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PGAM2—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—RFK—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM3—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MBTPS1—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT2B1—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAGLU—prostate cancer	4.29e-05	0.000323	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TYMS—prostate cancer	4.22e-05	0.000318	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	4.19e-05	0.000316	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—prostate cancer	4.17e-05	0.000314	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPL—prostate cancer	4.09e-05	0.000308	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TYMS—prostate cancer	4.09e-05	0.000308	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SRD5A2—prostate cancer	4.07e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP3A43—prostate cancer	4.07e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—DEGS1—prostate cancer	4.07e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAT1—prostate cancer	4.07e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AMACR—prostate cancer	4.07e-05	0.000306	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—prostate cancer	4.04e-05	0.000304	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	4e-05	0.000301	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.97e-05	0.000299	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPL—prostate cancer	3.97e-05	0.000299	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—prostate cancer	3.95e-05	0.000298	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ERCC2—prostate cancer	3.92e-05	0.000295	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B1—prostate cancer	3.88e-05	0.000292	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.88e-05	0.000292	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—prostate cancer	3.83e-05	0.000289	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ERCC2—prostate cancer	3.8e-05	0.000286	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.73e-05	0.000281	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.71e-05	0.000279	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—prostate cancer	3.68e-05	0.000277	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.67e-05	0.000277	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARA—prostate cancer	3.62e-05	0.000272	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—prostate cancer	3.57e-05	0.000269	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARA—prostate cancer	3.51e-05	0.000264	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.5e-05	0.000263	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPGD—prostate cancer	3.46e-05	0.00026	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—B4GALT4—prostate cancer	3.46e-05	0.00026	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAV1—prostate cancer	3.4e-05	0.000256	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAV1—prostate cancer	3.3e-05	0.000248	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TNFRSF21—prostate cancer	3.25e-05	0.000245	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP7B1—prostate cancer	3.16e-05	0.000238	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTAP—prostate cancer	3.16e-05	0.000238	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—prostate cancer	3.1e-05	0.000233	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	3.09e-05	0.000233	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT1E1—prostate cancer	3.08e-05	0.000232	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SRD5A1—prostate cancer	3.08e-05	0.000232	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—prostate cancer	3e-05	0.000226	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.99e-05	0.000225	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.95e-05	0.000222	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACSL4—prostate cancer	2.94e-05	0.000221	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B3—prostate cancer	2.94e-05	0.000221	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—prostate cancer	2.93e-05	0.000221	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.91e-05	0.000219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CREBBP—prostate cancer	2.87e-05	0.000216	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—prostate cancer	2.84e-05	0.000214	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ARG2—prostate cancer	2.82e-05	0.000212	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PHGDH—prostate cancer	2.82e-05	0.000212	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UMPS—prostate cancer	2.82e-05	0.000212	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.8e-05	0.000211	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CREBBP—prostate cancer	2.78e-05	0.00021	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LDHB—prostate cancer	2.76e-05	0.000208	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CD—prostate cancer	2.72e-05	0.000205	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP3A5—prostate cancer	2.71e-05	0.000204	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CD—prostate cancer	2.64e-05	0.000199	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PDHA1—prostate cancer	2.62e-05	0.000197	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA3—prostate cancer	2.62e-05	0.000197	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TCN2—prostate cancer	2.62e-05	0.000197	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UCP3—prostate cancer	2.62e-05	0.000197	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—prostate cancer	2.57e-05	0.000194	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD3B1—prostate cancer	2.5e-05	0.000188	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC22A3—prostate cancer	2.5e-05	0.000188	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—prostate cancer	2.49e-05	0.000188	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.43e-05	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA4—prostate cancer	2.4e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TBXAS1—prostate cancer	2.4e-05	0.00018	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CB—prostate cancer	2.37e-05	0.000179	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—prostate cancer	2.35e-05	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.34e-05	0.000176	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA2—prostate cancer	2.34e-05	0.000176	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT1A1—prostate cancer	2.31e-05	0.000174	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG5—prostate cancer	2.31e-05	0.000174	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CB—prostate cancer	2.3e-05	0.000173	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—prostate cancer	2.28e-05	0.000172	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA1—prostate cancer	2.25e-05	0.00017	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTO1—prostate cancer	2.23e-05	0.000168	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAT2—prostate cancer	2.23e-05	0.000168	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD3B2—prostate cancer	2.23e-05	0.000168	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.14e-05	0.000161	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2C18—prostate cancer	2.14e-05	0.000161	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLCB2—prostate cancer	2.14e-05	0.000161	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LRP2—prostate cancer	2.14e-05	0.000161	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—P4HB—prostate cancer	2.09e-05	0.000158	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—prostate cancer	2.05e-05	0.000154	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC22A1—prostate cancer	2.04e-05	0.000153	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.01e-05	0.000152	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—prostate cancer	1.99e-05	0.00015	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.99e-05	0.00015	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—EP300—prostate cancer	1.95e-05	0.000147	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MED12—prostate cancer	1.95e-05	0.000147	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNG5—prostate cancer	1.94e-05	0.000146	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—EP300—prostate cancer	1.9e-05	0.000143	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA3—prostate cancer	1.87e-05	0.000141	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.83e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPGDS—prostate cancer	1.78e-05	0.000134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.77e-05	0.000133	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—prostate cancer	1.73e-05	0.00013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACHE—prostate cancer	1.73e-05	0.00013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.71e-05	0.000129	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.7e-05	0.000128	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.66e-05	0.000125	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PRKACB—prostate cancer	1.65e-05	0.000124	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.64e-05	0.000123	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.61e-05	0.000121	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA2—prostate cancer	1.56e-05	0.000117	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.49e-05	0.000112	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.45e-05	0.000109	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—prostate cancer	1.45e-05	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NQO1—prostate cancer	1.44e-05	0.000108	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TH—prostate cancer	1.41e-05	0.000107	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.41e-05	0.000106	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—prostate cancer	1.4e-05	0.000106	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.4e-05	0.000105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.39e-05	0.000105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.38e-05	0.000104	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GGT1—prostate cancer	1.33e-05	0.0001	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA1—prostate cancer	1.31e-05	9.89e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.29e-05	9.75e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—RXRA—prostate cancer	1.25e-05	9.4e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.21e-05	9.15e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COMT—prostate cancer	1.2e-05	9.06e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—prostate cancer	1.2e-05	9.02e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—prostate cancer	1.18e-05	8.9e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ITPR1—prostate cancer	1.18e-05	8.87e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.16e-05	8.72e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—prostate cancer	1.15e-05	8.63e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TYMS—prostate cancer	1.11e-05	8.38e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—prostate cancer	1.1e-05	8.29e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPL—prostate cancer	1.08e-05	8.13e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.04e-05	7.86e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ERCC2—prostate cancer	1.03e-05	7.79e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—prostate cancer	9.72e-06	7.32e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARA—prostate cancer	9.54e-06	7.18e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAV1—prostate cancer	8.97e-06	6.75e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.57e-06	6.45e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.17e-06	6.15e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—prostate cancer	7.73e-06	5.82e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CREBBP—prostate cancer	7.58e-06	5.7e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.18e-06	5.41e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—prostate cancer	6.78e-06	5.11e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.26e-06	4.71e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—prostate cancer	6.2e-06	4.67e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—prostate cancer	5.41e-06	4.07e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—EP300—prostate cancer	5.16e-06	3.89e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.82e-06	2.87e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—prostate cancer	3.12e-06	2.35e-05	CbGpPWpGaD
